This company has been marked as potentially delisted and may not be actively trading. Amedica (AMDA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock AMDA vs. INFU, CTCX, NSPR, TMDIF, HSAQ, GBS, RVP, PETV, BTCY, and IVFShould you be buying Amedica stock or one of its competitors? The main competitors of Amedica include InfuSystem (INFU), Carmell (CTCX), InspireMD (NSPR), Titan Medical (TMDIF), Health Sciences Acquisitions Co. 2 (HSAQ), GBS (GBS), Retractable Technologies (RVP), PetVivo (PETV), Biotricity (BTCY), and INVO Fertility (IVF). These companies are all part of the "medical" sector. Amedica vs. Its Competitors InfuSystem Carmell InspireMD Titan Medical Health Sciences Acquisitions Co. 2 GBS Retractable Technologies PetVivo Biotricity INVO Fertility InfuSystem (NYSE:INFU) and Amedica (NASDAQ:AMDA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk. Is INFU or AMDA more profitable? InfuSystem has a net margin of 1.12% compared to Amedica's net margin of -139.62%. InfuSystem's return on equity of 2.78% beat Amedica's return on equity.Company Net Margins Return on Equity Return on Assets InfuSystem1.12% 2.78% 1.41% Amedica -139.62%-148.60%-67.83% Does the media refer more to INFU or AMDA? In the previous week, InfuSystem had 11 more articles in the media than Amedica. MarketBeat recorded 11 mentions for InfuSystem and 0 mentions for Amedica. InfuSystem's average media sentiment score of 0.78 beat Amedica's score of 0.00 indicating that InfuSystem is being referred to more favorably in the media. Company Overall Sentiment InfuSystem Positive Amedica Neutral Which has more volatility and risk, INFU or AMDA? InfuSystem has a beta of 1.81, indicating that its stock price is 81% more volatile than the S&P 500. Comparatively, Amedica has a beta of -1.24, indicating that its stock price is 224% less volatile than the S&P 500. Which has better earnings & valuation, INFU or AMDA? InfuSystem has higher revenue and earnings than Amedica. Amedica is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInfuSystem$137.58M0.91$870K$0.1442.39Amedica$11.23M2.96-$9.32M-$3.13-0.89 Do analysts prefer INFU or AMDA? InfuSystem presently has a consensus price target of $12.50, indicating a potential upside of 110.61%. Given InfuSystem's stronger consensus rating and higher possible upside, equities analysts plainly believe InfuSystem is more favorable than Amedica.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 3 Strong Buy rating(s) 4.00Amedica 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals believe in INFU or AMDA? 71.1% of InfuSystem shares are held by institutional investors. Comparatively, 3.7% of Amedica shares are held by institutional investors. 11.4% of InfuSystem shares are held by company insiders. Comparatively, 0.9% of Amedica shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryInfuSystem beats Amedica on 15 of the 16 factors compared between the two stocks. Get Amedica News Delivered to You Automatically Sign up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMDA vs. The Competition Export to ExcelMetricAmedicaSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$33.24M$70.61M$5.73B$9.54BDividend YieldN/AN/A4.70%4.06%P/E Ratio-0.896.4728.3720.10Price / Sales2.96148.78467.87102.67Price / CashN/A18.4125.1828.38Price / Book1.568.188.635.85Net Income-$9.32M-$25.92M$3.25B$259.11M Amedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMDAAmedicaN/A$2.80+2.9%N/A-46.9%$33.24M$11.23M-0.89N/AINFUInfuSystem3.4218 of 5 stars$5.91-0.9%$12.50+111.7%N/A$124.10M$137.58M98.43410CTCXCarmellN/A$4.16flatN/A+288.0%$86.97M$32.84K0.0014NSPRInspireMD2.5285 of 5 stars$2.46-1.0%$4.50+83.3%-28.3%$75.24M$7.03M-3.2750TMDIFTitan MedicalN/A$0.39+10.7%N/A+840.8%$44.44M$17.63M-0.3150Gap UpHSAQHealth Sciences Acquisitions Co. 2N/A$3.20+1.3%N/A-56.3%$35.88MN/A0.004GBSGBSN/A$2.25+10.8%N/A+7.3%$33.50MN/A-4.027Gap UpRVPRetractable Technologies1.9594 of 5 stars$0.70+1.4%N/A-37.4%$21.02M$33.75M-1.30240PETVPetVivoN/A$0.80-3.3%N/A+23.1%$19.54M$1.05M-1.7820BTCYBiotricityN/A$0.50+0.2%N/A-35.5%$12.45M$12.06M-0.4640Gap DownIVFINVO FertilityN/A$2.17-16.5%N/A-92.4%$1.56M$6.53M-0.0225Negative NewsStock Split Related Companies and Tools Related Companies InfuSystem Competitors Carmell Competitors InspireMD Competitors Titan Medical Competitors Health Sciences Acquisitions Co. 2 Competitors GBS Competitors Retractable Technologies Competitors PetVivo Competitors Biotricity Competitors INVO Fertility Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMDA) was last updated on 7/28/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Dollar’s Crashing—What Are You Doing About It?The U.S. dollar is down 10.8%—its steepest drop since 1973. As global confidence in the dollar fades, centr...Lear Capital | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
